LTR Pharma Limited (ASX:LTP)
Australia · Delayed Price · Currency is AUD 0.3900
-0.0100 (-2.50%)
At close: Mar 30, 2026
LTR Pharma Market Cap
LTR Pharma has a market cap or net worth of 73.62 million as of March 31, 2026. Its market cap has decreased by -32.20% in one year.
Market Cap
73.62M
Enterprise Value
47.84M
Revenue
1.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.39
Market Cap Chart
Since December 11, 2023, LTR Pharma's market cap has increased from 52.98M to 73.62M, an increase of 38.96%. That is a compound annual growth rate of 15.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 70.89M | -45.79% |
| Dec 31, 2025 | 130.78M | -10.78% |
| Dec 31, 2024 | 146.59M | 204.77% |
| Dec 29, 2023 | 48.10M | -9.21% |
| Dec 11, 2023 | 52.98M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Island Pharmaceuticals | 109.32M |
| Botanix Pharmaceuticals | 90.94M |
| Alterity Therapeutics | 87.00M |
| Arovella Therapeutics | 82.09M |
| Cynata Therapeutics | 71.24M |
| Radiopharm Theranostics | 70.88M |
| Immutep | 70.74M |
| Prescient Therapeutics | 58.88M |